Healthtech Startups

Mytonomy provides a cloud-based platform that delivers video and multimedia content to enable patient education and engagement with healthcare providers. The platform serves health systems, health plans, and healthcare organizations to improve patient outcomes and reduce care costs through digital patient engagement.

2 investors

Weimai is a digital health platform providing comprehensive, full-cycle healthcare services to populations across China through AI-powered disease management technology. The company operates China's largest full-condition management service platform, partnering with hospitals and healthcare providers to deliver personalized medical and wellness services.

2 investors

Nadia Care provides comprehensive maternal support through multidisciplinary teams led by Maternity Navigators, offering in-person and virtual care throughout pregnancy and postpartum. The service aims to improve maternal health outcomes for families and is recognized as a preferred vendor by community health plans nationwide.

2 investors

Nadia Care provides maternity support during pregnancy and after birth, pairing members with maternity coaches and a care team for prenatal, labor, feeding, nutritional, mental health, and postpartum help. It works alongside members' doctors and connects them to local community resources such as housing and transportation.

2 investors

Naluri develops digital therapeutics that combine behavioral science and coaching to help individuals reduce chronic disease risk, improve mental resilience, and build lasting healthy habits. The company serves employers across Southeast Asia.

2 investors

Nanos Medical is a Chinese medical device company specializing in otorhinolaryngology and minimally invasive surgery equipment, offering diagnostic and surgical solutions for ENT and head-neck procedures. The company manufactures and distributes medical consumables, plasma surgery systems, endoscopic cameras, and related surgical instruments.

2 investors

Nanostics is a precision health company developing non-invasive diagnostic tests and medical devices that use machine learning to detect and assess aggressive cancers such as prostate cancer, aiming to improve diagnosis and healthcare decisions. It serves clinicians and patients in the cancer diagnostics field.

2 investors

NanoString (part of Bruker Spatial Biology) develops instruments and assays for spatial biology and gene expression analysis, including single-cell and subcellular spatial transcriptomics, proteomics, and multiomics. Its systems serve researchers in oncology, biomarker discovery, neuroscience, and translational and clinical research.

2 investors

Nanovery develops DNA-based nanorobotic sensors that quantify nucleic acid sequences, such as RNA therapeutics and biomarkers, in liquid samples using a standard plate reader. The platform serves biotechnology research and therapeutic analysis workflows.

2 investors

Narrable Health provides an AI platform for home health agencies that automates administrative and clinical documentation work, including AI-generated OASIS notes, compliance QA, billing, and referral growth. It serves home health organizations across roles such as executives, directors of nursing, operations, and finance.

2 investors

NVA is a network of over 1,000 companion animal hospitals and 140+ specialty/emergency veterinary facilities, along with boarding, grooming, and equine care services, serving pet owners across North America. The company operates through multiple integrated business units delivering comprehensive veterinary medicine and pet care services.

2 investors

NAVAN develops a non-perturbative intracellular delivery technology that transports a wide range of cargo types into primary cell types while preserving cell viability and function. The company applies this platform to cell and gene therapy development across multiple indications through strategic partnerships.

2 investors

Navitas Life Sciences is a global clinical research partner providing clinical, regulatory, safety, and data management solutions to pharmaceutical, biotech, and federal agencies for drug development and patient safety. The company combines industry expertise with proprietary technology platforms to accelerate clinical trials and regulatory processes.

2 investors

Navi develops a medical device — an ECG-based catheter tip location system for newborn and pediatric patients — to help doctors and nurses in neonatal and pediatric intensive care units deliver better vascular access care. The company works with clinicians internationally to improve pediatric patient outcomes.

2 investors

Nectero Therapeutics develops therapeutic devices for vascular medicine, working with key opinion leaders in the field. The company operates in the medical device and biotech space.

2 investors

Nectome provides cryogenic preservation of the human body and brain shortly after legal death, aiming to preserve neural structure in sufficient detail that future revival may become theoretically possible. The service targets individuals at end-of-life seeking experimental preservation as a potential pathway to future recovery.

2 investors

Nektar develops therapies that modulate the immune system to treat autoimmune diseases and inflammatory conditions, targeting the root causes of immune dysfunction. The company conducts research, therapeutic discovery, and clinical development, working with pharmaceutical partners to bring immune-mediated disease treatments to patients.

2 investors

NeoBe Therapeutics develops engineered live biotherapeutics for oncology, combining synthetic biology and immunology to create next-generation cell therapies. The company serves cancer patients through collaborations with leading academic institutions and investors.

2 investors

NeoChord develops a medical device system for beating heart mitral valve repair in patients with mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, has received CE market clearance in Europe.

2 investors

NeoDocs provides at-home health assessment tests with lab-quality accuracy and personalized health monitoring for consumers seeking preventive wellness. The company focuses on proactive health optimization rather than disease treatment.

2 investors

Neopathology develops tissue diagnostic assays and a proprietary platform called ONEPATHOLOGY that delivers rapid, accurate disease diagnosis and patient stratification for precision medicine treatments. The company combines spatial biology and deep-tissue profiling technologies to standardize tissue diagnostics.

2 investors

2 investors

Neru Health provides an AI-powered operations platform for durable medical equipment (DME) suppliers to automate patient onboarding, compliance management, therapy adherence monitoring, and equipment resupply workflows. The platform integrates with existing DME software and clinical systems to reduce operating costs and improve patient outcomes.

2 investors

NervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair. It maintains a drug pipeline and operates as a publicly traded company.

2 investors